A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.
Manjaro? I use that on my computer!
Oh, you said Mounjaro? Never mind.
“I use Arch btw”
Manjaro users don’t have the superiority complex required to be this prude.